Risk factors
Tevogen (TVGN) risk factors
Item 1A of every Tevogen Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors68 risks3 new3 reworded
Tevogen faces severe liquidity constraints, relying on debt, stock sales, and grants for TVGN 489 development.
Filed Mar 31, 2026 - FY2024 10-K risk factors65 risks
Tevogen is a clinical-stage immunotherapy company relying on external grants and financing to fund operations since it has no commercial products.
Filed Apr 02, 2025